Incidence of ineffective safety margin testing (<10Â J) and efficacy of routine subcutaneous array insertion during implantable cardioverter defibrillator implantation

SMT <10 J occur in about 2.6% of patients undergoing ICD implantation. SQA insertion corrects this problem without procedural/mid-term complications.